Towards an immunotherapy for p185HER2 overexpressing tumors.
作者信息
Carter P, Rodrigues M L, Lewis G D, Figari I, Shalaby M R
机构信息
Department of Protein Engineering, Genentech Inc., South San Francisco, CA 94080.
出版信息
Adv Exp Med Biol. 1994;353:83-94. doi: 10.1007/978-1-4615-2443-4_9.
PMID:7985544
Abstract
摘要
相似文献
1
Towards an immunotherapy for p185HER2 overexpressing tumors.针对p185HER2过表达肿瘤的免疫疗法。
Adv Exp Med Biol. 1994;353:83-94. doi: 10.1007/978-1-4615-2443-4_9.
2
Intervention in receptor tyrosine kinase-mediated pathways: recombinant antibody fusion proteins targeted to ErbB2.受体酪氨酸激酶介导途径的干预：靶向ErbB2的重组抗体融合蛋白
Curr Top Microbiol Immunol. 1996;213 ( Pt 3):113-28. doi: 10.1007/978-3-642-80071-9_8.
3
A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells.一种用于癌症免疫治疗的高效稳定双特异性双抗体：双特异性双抗体与T-LAK细胞治愈异种移植肿瘤
Cancer Immunol Immunother. 2004 Jun;53(6):497-509. doi: 10.1007/s00262-003-0465-9. Epub 2003 Nov 25.
4
Bispecific HER2 x CD3 antibodies enhance T-cell cytotoxicity in vitro and localize to HER2-overexpressing xenografts in nude mice.双特异性HER2 x CD3抗体在体外增强T细胞细胞毒性，并在裸鼠体内定位于HER2过表达的异种移植瘤。
Clin Immunol Immunopathol. 1995 Feb;74(2):185-92. doi: 10.1006/clin.1995.1027.
5
Improving the efficacy of antibody-based cancer therapies.提高基于抗体的癌症治疗的疗效。
Nat Rev Cancer. 2001 Nov;1(2):118-29. doi: 10.1038/35101072.
6
Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells.双特异性单克隆抗体和人T细胞对异种移植的人类肿瘤的治疗作用
Science. 1994 May 6;264(5160):833-5. doi: 10.1126/science.8171337.
7
EGF mutant receptor vIII as a molecular target in cancer therapy.表皮生长因子（EGF）突变受体vIII作为癌症治疗中的分子靶点。
Endocr Relat Cancer. 2001 Jun;8(2):83-96. doi: 10.1677/erc.0.0080083.
8
Engineering high affinity humanized anti-p185HER2/anti-CD3 bispecific F(ab')2 for efficient lysis of p185HER2 overexpressing tumor cells.工程化高亲和力人源化抗p185HER2/抗CD3双特异性F(ab')2以有效裂解p185HER2过表达的肿瘤细胞。
Int J Cancer. 1995 Jul 28;62(3):319-24. doi: 10.1002/ijc.2910620315.
9
Anti-p185HER2 monoclonal antibodies: biological properties and potential for immunotherapy.
Cancer Treat Res. 1992;61:193-211. doi: 10.1007/978-1-4615-3500-3_10.
10
Engineering antibodies for therapy.用于治疗的工程抗体。
Curr Pharm Biotechnol. 2002 Sep;3(3):237-56. doi: 10.2174/1389201023378256.
Zotero 插件